Fact checked by Nick Blackmer Key Takeaways Foundayo is a newly approved GLP-1 weight loss pill that can be taken any time of ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Amazon will offer delivery of Eli Lilly's new weight-loss pill Foundayo and stock it at kiosks at some of the company's ...

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, constipation, or diarrhea.

Foundayo, a once-daily oral GLP-1 medication approved for obesity and weight-related issues, ranges in cost from $25 to $349 per month ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

Eli Lilly and Co. announced Thursday that its new weight-loss pill is now available in retail pharmacies in the United States ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies.

Korea’s biotech sector is churning out new fortunes as Big Pharma closes in with lucrative deals for everything from ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...